MSB 11.1% $1.10 mesoblast limited

Cell Therapy News/Articles, page-78

  1. 6,103 Posts.
    lightbulb Created with Sketch. 1048
    Smith & Nephew to purchase regenerative medicine company for $210M: 3 points

    Written by Mackenzie Garrity | Tuesday, 24 October 2017 20:44
    Social sharing

    Smith & Nephew plans to acquire Minnesota-based Rotation Medical, a developer of regenerative medicine technologies for patients suffering from rotator cuff disease, for $210 million, according to Reuters.

    Here are three points:

    1. Smith & Nephew will pay $125 million upfront followed by $85 million over the next five years if certain financial targets are met.

    2. The deal is supposed to close later this year, and while the purchase is not supposed to boost Smith & Nephew's earnings in 2018, the company expects earnings to increase in 2019.

    3. Rotation Medical develops tissue regeneration technology for shoulder rotator cuff repair. The sale of the company is cleared in the U.S. and a filing is being prepped in Europe.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.10
Change
0.110(11.1%)
Mkt cap ! $1.255B
Open High Low Value Volume
97.0¢ $1.11 95.5¢ $15.75M 15.06M

Buyers (Bids)

No. Vol. Price($)
5 79396 $1.10
 

Sellers (Offers)

Price($) Vol. No.
$1.11 60351 4
View Market Depth
Last trade - 16.10pm 01/05/2024 (20 minute delay) ?
Last
$1.10
  Change
0.110 ( 10.8 %)
Open High Low Volume
96.5¢ $1.11 95.5¢ 2700730
Last updated 15.59pm 01/05/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.